135 related articles for article (PubMed ID: 20609062)
1. In-situ absorption, protein binding and pharmacokinetic studies of S002-853, a novel antidiabetic and antidyslipidaemic flavone derivative in rats.
Gautam N; Kushwaha HN; Pratap R; Singh SK
J Pharm Pharmacol; 2010 May; 62(5):604-9. PubMed ID: 20609062
[TBL] [Abstract][Full Text] [Related]
2. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
Lal J; Gupta RC
Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatographic-tandem mass spectrometry assay for quantitation of a novel antidiabetic S002-853 in rat plasma and its application to pharmacokinetic study.
Gautam N; Singh RP; Pratap R; Singh SK
Biomed Chromatogr; 2010 Jul; 24(7):692-8. PubMed ID: 19877294
[TBL] [Abstract][Full Text] [Related]
4. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, in-situ absorption and protein binding studies of a new neuroleptic agent centbutindole in rats.
Issar M; Singh SK; Mishra B; Gupta RC
Eur J Pharm Sci; 2003 Jun; 19(2-3):105-13. PubMed ID: 12791412
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic study of four flavones of Glycyrrhiza in rat plasma using HPLC-MS.
Wu YP; Meng XS; Bao YR; Wang S
J Ethnopharmacol; 2013 Jun; 148(1):266-70. PubMed ID: 23643543
[TBL] [Abstract][Full Text] [Related]
7. Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.
Lou Y; Hu H; Liu Y; Yu Q; Li L; Ping L; Yu L; Jiang H; Zeng S
J Pharm Biomed Anal; 2011 Jul; 55(5):1163-9. PubMed ID: 21549539
[TBL] [Abstract][Full Text] [Related]
8. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of the novel, synthetic trioxane antimalarial compound 97-78 in rats using an LC-MS/MS method for quantification.
Singh RP; Sabarinath S; Gautam N; Gupta RC; Singh SK
Arzneimittelforschung; 2011; 61(2):120-5. PubMed ID: 21428247
[TBL] [Abstract][Full Text] [Related]
10. Bioanalytical LC-MS/MS method development and validation of novel antidiabetic candidate S007-1261 in rat plasma and its application to pharmacokinetic and oral bioavailability studies.
Misra A; Kushwaha HN; Gautam N; Singh B; Verma PC; Pratap R; Singh SK
Drug Res (Stuttg); 2014 Aug; 64(8):399-405. PubMed ID: 24258707
[TBL] [Abstract][Full Text] [Related]
11. Flavone-based novel antidiabetic and antidyslipidemic agents.
Verma AK; Singh H; Satyanarayana M; Srivastava SP; Tiwari P; Singh AB; Dwivedi AK; Singh SK; Srivastava M; Nath C; Raghubir R; Srivastava AK; Pratap R
J Med Chem; 2012 May; 55(10):4551-67. PubMed ID: 22524508
[TBL] [Abstract][Full Text] [Related]
12. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of brucine after intravenous and oral administration to rats.
Chen J; Xiao HL; Hu RR; Hu W; Chen ZP; Cai H; Liu X; Lu TL; Fang Y; Cai BC
Fitoterapia; 2011 Dec; 82(8):1302-8. PubMed ID: 21958965
[TBL] [Abstract][Full Text] [Related]
14. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
Lin HS; Ho PC
J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
[TBL] [Abstract][Full Text] [Related]
15. Determination of genkwanin in rat plasma by liquid chromatography-tandem mass spectrometry: application to a bioavailability study.
Song Y; Zhang S; Liu H; Jin X
J Pharm Biomed Anal; 2013 Oct; 84():129-34. PubMed ID: 23831487
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
Low BS; Ng BH; Choy WP; Yuen KH; Chan KL
Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032
[TBL] [Abstract][Full Text] [Related]
17. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
Choi YH; Kim SG; Lee MG
J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of oral pharmacokinetics, in vitro metabolism, blood partitioning and plasma protein binding of novel antidiabetic agent, S009-0629 in rats.
Valicherla GR; Italiya KS; Gupta CP; Mishra S; Riyazuddin M; Syed AA; Singh SK; Shahi S; Taneja G; Wahajuddin M; Goel A; Gayen JR
Drug Dev Res; 2018 Jun; 79(4):173-183. PubMed ID: 29989222
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats.
Choi JS; Choi HK; Shin SC
Int J Pharm; 2004 May; 275(1-2):165-70. PubMed ID: 15081147
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits.
Saxena A; Valicherla GR; Joshi P; Saxena R; Cheruvu SH; Bhunia SS; Jain GK; Siddiqui HH; Saxena AK; Gayen JR
Xenobiotica; 2015; 45(11):1016-23. PubMed ID: 26084373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
